As of May 31, 2025, Bioton SA (BIO.WA) reports a Forward P/E of N/A.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing Bioton SA's Forward P/E to Peers
To better understand Bioton SA's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| Bioton SA (BIO.WA) | - |
| Biofrontera AG (B8F.DE) | 72.66 |
| Eurobio Scientific SA (ALERS.PA) | 28.41 |
| Addex Therapeutics Ltd (ADXN.SW) | 11.37 |
| Kancera AB (KAN.ST) | 0.40 |
Compared to its competitors, Bioton SA's Forward P/E is difficult to compare due to insufficient data.